HDAC6 as privileged target in drug discovery: A perspective

S Pulya, SA Amin, N Adhikari, S Biswas, T Jha… - Pharmacological …, 2021 - Elsevier
Abstract HDAC6, a class IIB HDAC isoenzyme, stands unique in its structural and
physiological functions. Besides histone modification, largely due to its cytoplasmic …

Recent advance in oxazole-based medicinal chemistry

HZ Zhang, ZL Zhao, CH Zhou - European journal of medicinal chemistry, 2018 - Elsevier
Oxazole compounds containing nitrogen and oxygen atoms in the five-membered aromatic
ring are readily able to bind with a variety of enzymes and receptors in biological systems …

Chemical nematicides: Recent research progress and outlook

J Chen, QX Li, B Song - Journal of Agricultural and Food …, 2020 - ACS Publications
Plant-parasitic nematodes have caused huge economic losses to agriculture worldwide and
seriously threaten the sustainable development of modern agriculture. Chemical …

A review of progress in histone deacetylase 6 inhibitors research: structural specificity and functional diversity

XH Zhang, Qin-Ma, HP Wu, MY Khamis… - Journal of medicinal …, 2021 - ACS Publications
Histone deacetylases (HDACs) are essential for maintaining homeostasis by catalyzing
histone deacetylation. Aberrant expression of HDACs is associated with various human …

Histone deacetylase (HDAC) inhibitors in cancer: a patent review (2017-present)

C Zhao, H Dong, Q Xu, Y Zhang - Expert opinion on therapeutic …, 2020 - Taylor & Francis
Introduction: Histone deacetylase (HDAC) inhibitors play a crucial role in restoring the
balance of acetylation and deacetylation of lysine residues of histones and non-histone …

Strategies to design selective histone deacetylase inhibitors

J Melesina, CV Simoben, L Praetorius… - …, 2021 - Wiley Online Library
This review classifies drug‐design strategies successfully implemented in the development
of histone deacetylase (HDAC) inhibitors, which have many applications including cancer …

First-in-class hydrazide-based HDAC6 selective inhibitor with potent oral anti-inflammatory activity by attenuating NLRP3 inflammasome activation

K Yue, S Sun, G Jia, M Qin, X Hou… - Journal of Medicinal …, 2022 - ACS Publications
In this study, we report the first highly selective HDAC6 inhibitor with hydrazide as the zinc-
binding group (ZBG), which displays superior pharmacokinetic properties to the current …

Next-generation of selective histone deacetylase inhibitors

F Yang, N Zhao, D Ge, Y Chen - Rsc Advances, 2019 - pubs.rsc.org
Histone deacetylases (HDACs) are clinically validated epigenetic drug targets for cancer
treatment. HDACs inhibitors (HDACis) have been successfully applied against a series of …

Recent advances in the discovery of potent and selective HDAC6 inhibitors

XX Wang, RZ Wan, ZP Liu - European journal of medicinal chemistry, 2018 - Elsevier
Histone deacetylase HDAC6, a member of the class IIb HDAC family, is unique among
HDAC enzymes in having two active catalytic domains, and has unique physiological …

Photoinduced [3+ 2] Cycloaddition of Carbenes and Nitriles: A Versatile Approach to Oxazole Synthesis

A Saha, C Sen, S Guin, C Das, D Maiti… - Angewandte Chemie …, 2023 - Wiley Online Library
We have developed a photoinduced protocol for the synthesis of pharmaceutically important
oxazole molecules using diazo‐and nitrile‐containing reactants. The process involves the …